articleThe LancetApr 1, 2010GREEN OA

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study

HIHoward I. ScherTMTomasz M. BeerCSCelestia S. HiganoAAAseem AnandMTMary‐Ellen Taplin

Memorial Sloan Kettering Cancer Center · Oregon Health & Science University · +4 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

1,082
total citations
FWCI
110.54
Percentile
100%
References
30
Citations per year

Authors

19

Topics & keywords

Topics
Keywords
  • Medicine
  • Prostate cancer
  • Androgen receptor
  • Tolerability
  • Urology
  • Androgen
  • Internal medicine
  • Castration
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.